ADMA Biologics Inc (ADMA)
20.21
-1.26
(-5.89%)
USD |
NASDAQ |
Nov 14, 16:00
20.17
-0.04
(-0.20%)
After-Hours: 20:00
ADMA Biologics Cash from Operations (Quarterly): 25.03M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.03M |
| June 30, 2024 | 45.65M |
| March 31, 2024 | -2.218M |
| December 31, 2023 | 17.60M |
| September 30, 2023 | 11.98M |
| June 30, 2023 | -6.059M |
| March 31, 2023 | -14.72M |
| December 31, 2022 | -7.379M |
| September 30, 2022 | -13.28M |
| June 30, 2022 | -12.83M |
| March 31, 2022 | -26.01M |
| December 31, 2021 | -33.47M |
| September 30, 2021 | -13.41M |
| June 30, 2021 | -32.26M |
| March 31, 2021 | -33.23M |
| December 31, 2020 | -32.22M |
| September 30, 2020 | -23.85M |
| June 30, 2020 | -21.28M |
| March 31, 2020 | -24.65M |
| December 31, 2019 | -19.65M |
| September 30, 2019 | -23.63M |
| June 30, 2019 | -18.62M |
| March 31, 2019 | -14.29M |
| December 31, 2018 | -18.79M |
| September 30, 2018 | -12.54M |
| Date | Value |
|---|---|
| June 30, 2018 | -14.91M |
| March 31, 2018 | -16.43M |
| December 31, 2017 | -13.36M |
| September 30, 2017 | -9.739M |
| June 30, 2017 | -8.775M |
| March 31, 2017 | -5.398M |
| December 31, 2016 | -3.614M |
| September 30, 2016 | -4.683M |
| June 30, 2016 | -4.804M |
| March 31, 2016 | -5.168M |
| December 31, 2015 | -4.078M |
| September 30, 2015 | -2.673M |
| June 30, 2015 | -4.446M |
| March 31, 2015 | -4.221M |
| December 31, 2014 | -2.902M |
| September 30, 2014 | -2.466M |
| June 30, 2014 | -4.296M |
| March 31, 2014 | -5.040M |
| December 31, 2013 | -2.960M |
| September 30, 2013 | -2.226M |
| June 30, 2013 | -2.627M |
| March 31, 2013 | -3.075M |
| December 31, 2012 | -1.807M |
| September 30, 2012 | -2.101M |
| June 30, 2012 | -0.9969M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.47M
Minimum
Dec 2021
45.65M
Maximum
Jun 2024
-10.81M
Average
-14.07M
Median
Cash from Operations (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 73.83M |
| Madrigal Pharmaceuticals Inc | -66.98M |
| Assembly Biosciences Inc | -17.10M |
| TG Therapeutics Inc | -12.20M |
| Krystal Biotech Inc | 58.86M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.098M |
| Cash from Financing (Quarterly) | -25.47M |
| Free Cash Flow | 78.82M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.64% |